27.82
+0.13
+(0.47%)
As of 11:33:00 AM GMT-3. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
49,534,505.00
46,508,558.00
22,987,443.00
20,381,883.00
14,029,408.00
Cost of Revenue
40,286,197.00
38,937,076.00
17,785,662.00
15,572,114.00
11,462,348.00
Gross Profit
9,248,308.00
7,571,482.00
5,201,781.00
4,809,769.00
2,567,060.00
Operating Expense
2,131,645.00
2,199,582.00
1,462,571.00
1,241,841.00
947,874.00
Operating Income
7,116,663.00
5,371,900.00
3,739,210.00
3,567,928.00
1,619,186.00
Net Non Operating Interest Income Expense
-5,741,558.00
-6,105,611.00
-3,516,728.00
-2,149,067.00
-1,129,208.00
Pretax Income
4,704,096.00
2,550,344.00
1,325,264.00
2,032,616.00
483,457.00
Tax Provision
913,287.00
436,643.00
62,947.00
354,881.00
24,034.00
Net Income Common Stockholders
3,690,076.00
2,040,722.00
1,194,966.00
1,575,306.00
428,329.00
Diluted NI Available to Com Stockholders
3,690,076.00
2,040,722.00
1,194,966.00
1,575,306.00
428,329.00
Basic EPS
1.64
0.91
0.53
0.80
0.22
Diluted EPS
1.64
0.91
0.53
0.80
0.22
Basic Average Shares
2,245,214.75
2,254,607.00
2,254,304.00
1,971,453.00
1,942,526.00
Diluted Average Shares
2,245,214.75
2,254,607.00
2,258,804.00
1,977,013.00
1,949,146.00
Rent Expense Supplemental
138,299.00
128,705.00
119,773.00
97,581.00
45,006.00
Total Expenses
42,417,842.00
41,136,658.00
19,248,233.00
16,813,955.00
12,410,222.00
Net Income from Continuing & Discontinued Operation
3,690,076.00
2,040,722.00
1,194,966.00
1,575,306.00
428,329.00
Normalized Income
485,327.49
-222,651.11
721,074.20
659,286.08
-1,083,852.57
Interest Income
--
3,754,271.00
1,459,353.00
563,670.00
299,614.00
Interest Expense
3,836,989.00
4,000,324.00
3,346,193.00
1,874,173.00
1,340,741.00
Net Interest Income
-5,741,558.00
-6,105,611.00
-3,516,728.00
-2,149,067.00
-1,129,208.00
EBIT
8,541,085.00
6,550,668.00
4,671,457.00
3,906,789.00
1,824,198.00
EBITDA
10,015,584.00
8,050,701.00
6,075,599.00
5,135,459.00
2,668,725.00
Reconciled Cost of Revenue
40,286,197.00
38,937,076.00
17,785,662.00
15,572,114.00
11,462,348.00
Reconciled Depreciation
1,474,499.00
1,500,033.00
1,404,142.00
1,228,670.00
844,527.00
Net Income from Continuing Operation Net Minority Interest
3,690,076.00
2,040,722.00
1,194,966.00
1,575,306.00
428,329.00
Total Unusual Items Excluding Goodwill
3,976,841.00
2,730,935.00
497,523.00
1,109,780.00
1,591,289.00
Total Unusual Items
3,976,841.00
2,730,935.00
497,523.00
1,109,780.00
1,591,289.00
Normalized EBITDA
6,038,743.00
5,319,766.00
5,578,076.00
4,025,679.00
1,077,436.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
772,092.49
467,561.89
23,631.20
193,760.08
79,107.43
12/31/2020 - 12/15/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ONCO3.SA Oncoclínicas do Brasil Serviços Médicos S.A.
2.2800
+4.09%
IHHHF IHH Healthcare Berhad
1.1900
0.00%
300015.SZ Aier Eye Hospital Group Co., Ltd.
12.38
+0.08%
FORTIS.BO Fortis Healthcare Limited
616.20
-3.08%
BDMS.BK Bangkok Dusit Medical Services Public Company Limited
23.60
-0.42%
4002.SR Mouwasat Medical Services Company
90.00
+0.56%
4013.SR Dr. Sulaiman Al Habib Medical Services Group Company
292.00
+1.11%
AGL agilon health, inc.
3.6400
-1.36%
DVA DaVita Inc.
169.81
-0.05%